Cello Health Plc Ord 10P is listed on the London Stock Exchange trading with ticker code CLL.L, and is part of the Media sector. It has a market capitalisation of £13,932m, with approximately 105m shares in issue. Over the last year, Cello Group Plc share price has been traded in a range of 44.5, hitting a high of 139.50, and a low of 95.00.
Cello Group Plc, officially known as Cello Health Plc Ord 10P was formed in May of 2004, making the company fifteen years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 169.87 million GBX with gross profits of 80.98 million, or 0.7731 per issued share, and a pre-tax profit margin of 2.23%. Cello Group Plc currently has 6 directors, and has had 5 previous directors over the last 15 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 54.56 million paid in salaries to the 919 staff (average wage of 59 thousand), with the directors receiving an average 197 thousand each. In the accounts filed in 2014, the company paid 2559000 in dividends, or 0.0244 per share.
Cello Group Plc is in the Media sector.
|Intercede Group Plc (IGP.L)|
|Impax Asset Management Group Plc (IPX.L)|
|Proteome Sciences Plc (PRM.L)|
|Bloomsbury Publishing Plc (BMY.L)|
|Stv Group Plc (STVG.L)|
|Shares in Issue||105m|
|52 Week High||139.50|
|52 Week Low||95.00|